Indian Hospital Chain To Enter Drug-Making Business By Buying Firm
This article was originally published in PharmAsia News
Executive Summary
India's largest hospital chain plans to get into the pharmaceutical business through an acquisition and into clinical trials in collaboration with foreign companies. Apollo Hospitals sees an opportunity to get into the drugs end of the health care at a time of depressed prices brought on by a bad global economy. Apollo, through a wholly owned subsidiary, already is close to signing joint ventures with two U.S. companies for Phase I and II trials of cancer and heart drugs. The Apollo group also conducts Phase III trials for several companies. (Click here for more